Aesthetic Medicine R&D
What it does
For R&D, regulatory, and product managers working on aesthetic medicine products. These are medical devices, outside the cosmetics, food, and supplement categories covered by Formulation Development, so they have their own agent. It answers questions like:
- Who holds registrations for a product type (for example cross-linked sodium hyaluronate gel for injection) in China and the US, whether the product is made locally or imported, when it was first registered, and through which regulatory pathway;
- Which complications are reported most for that product type, whether there have been recalls, and where the safety signals are;
- Whether an indication or claim has clinical evidence, and how strong it is;
- How swelling and modulus of a cross-linked hyaluronic acid gel change with cross-linking, charge and concentration; what happens on dilution, in a salt bath or under compression; and calibrating the model to your own rheology and swelling measurements.
How it works
- Routing — your question goes to one or more lanes: registrations and landscape, safety signals, clinical evidence, material modeling, data calibration.
- Registrations — China from a snapshot of the national device unique-identifier database (aggregated by registration certificate), the US from public FDA data (product codes, PMA / 510(k) devices), reported side by side per market.
- Safety and evidence — US adverse event reports and recalls, literature and trial registrations, with key claims graded.
- Material modeling — a charged-swelling and viscoelastic relaxation model gives direction and magnitude; with measurements it calibrates parameters and reports held-out error and reliability warnings.
- Write-up and self-check — reports state data sources, snapshot or query dates and caveats, with citations and numbers checked before delivery.
What it delivers
- Registration landscape tables and timelines per market (holders, local vs imported, first-registration year, pathway);
- Safety signal lists and clinical evidence tables, each item sourced;
- Gel model results or calibrated parameters, stating explicitly whether parameters were calibrated to measurements;
- On request: a PDF report.
Limits
- China registration data is a snapshot of the officially published database. It covers only products with an assigned unique identifier and has no approval date, expiry or cancellation status. “Not in the database” does not mean “not registered”; current validity has to be checked with the regulator.
- Adverse event reports have no denominator: they cannot be turned into incidence rates or used to compare the safety of different products.
- The gel model’s default parameters are assumptions; before calibration only the direction is meaningful.
- It does not give treatment plans or complication management for individual patients, and does not write registration dossiers.
Orphic